tazobactam has been researched along with acetaminophen in 2 studies
| Studies (tazobactam) | Trials (tazobactam) | Recent Studies (post-2010) (tazobactam) | Studies (acetaminophen) | Trials (acetaminophen) | Recent Studies (post-2010) (acetaminophen) |
|---|---|---|---|---|---|
| 1,327 | 153 | 694 | 20,696 | 2,848 | 8,242 |
| Protein | Taxonomy | tazobactam (IC50) | acetaminophen (IC50) |
|---|---|---|---|
| Myoglobin | Homo sapiens (human) | 2.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Argento, AC; Heavner, MS; Ruggero, MA; Topal, JE | 1 |
1 review(s) available for tazobactam and acetaminophen
| Article | Year |
|---|---|
Molecular Adsorbent Recirculating System (MARS(®)) removal of piperacillin/tazobactam in a patient with acetaminophen-induced acute liver failure.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Overdose; Female; Humans; Inactivation, Metabolic; Liver Failure, Acute; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam | 2013 |
1 other study(ies) available for tazobactam and acetaminophen
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |